Fifth ranked UFC welterweight Hector Lombard failed his UFC 182 fight night drug test according to a Nevada Athletic Commission report.
Lombard, who defeated Josh Burkman via unanimous decision at UFC 182 on January 3rd, tested positive for the steroid desoxymethyltestosterone, which is sometimes referred to as “DMT” (no, not that DMT).
As confirmed by the UFC, the results of the failed drug test was the reason why Lombard’s April 25th, UFC 186 co-main event bout with number two ranked Rory MacDonald has been cancelled. The bout has since been replaced by a flyweight title bout between current champion Demetrious Johnson and contender Kyoji Horiguchi.
According to the report, obtained by MMAFighting, the drug test results were sent to the NAC on January 13th by the Quest Diagnostics lab in Kansas.
The UFC has released the following statement regarding Lombard:
The UFC has been notified by the Nevada State Athletic Commission that UFC welterweight Hector Lombard has tested positive for a banned substance following his fight at UFC 182: Jones vs. Cormier on Jan. 3, 2015 in Las Vegas, Nev. The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by our athletes. As a result of his positive test, Lombard has been informed that he has violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC will cooperate with the commission on the matter and fully supports Lombard’s right to a due process hearing before the commission.
Lombard has declined to comment on the situation.
